Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

NCT06972615
Recruiting
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy
Phase 2 · Argentina · 1 site
Registry update: 28 May 2026
NCT07483970
Recruiting
A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.
Phase 1 · China · 1 site
Registry update: 6 Aug 2026
NCT07855926
Recruiting
Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)
Not applicable · Germany · 1 site
Registry update: 2 Oct 2026
NCT07566156
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Phase 3 · Canada, Germany, Spain, France, Italy, South Korea, Taiwan, United States · 66 sites
Registry update: 28 Oct 2026
2025-522963-14-00
Recruiting
A FIH study to investigate the safety and preliminary efficacy of expanded autologous urothelial cells bioprinted during orthotopic neobladder surgery
Phase 1 · Greece · 2 sites
Registry update: 23 Oct 2026
NCT07498907
Recruiting
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
Phase 3 · China · 1 site
Registry update: 28 Sept 2026
NCT07739121
Recruiting
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Not applicable · France · 5 sites
Registry update: 7 Oct 2026
NCT07557225
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Not applicable · China · 1 site
Registry update: 14 May 2026
NCT07419295
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Greece, Israel, Italy, Japan, Netherlands, Sweden, United States · 132 sites
Registry update: 10 Nov 2026
NCT07602010
Recruiting
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Not applicable · Norway · 1 site
Registry update: 22 May 2026
NCT07416123
Recruiting
A Study of GEN1106 in Participants With Solid Tumors
Phase 1 · Spain, Japan, United States · 10 sites
Registry update: 3 Nov 2026
NCT07439120
Recruiting
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
Early phase 1 · China · 1 site
Registry update: 3 Jun 2026
NCT07322263
Recruiting
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Phase 2 · United States · 1 site
Registry update: 17 Apr 2026
NCT07532902
Recruiting
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Phase 1 · United States · 7 sites
Registry update: 16 Sept 2026
NCT07888374
Recruiting
Urinary Cell-Free DNA Liquid Biopsy for Urothelial Cancer Diagnosis and Origin Identification
Not applicable · China · 1 site
Registry update: 22 Oct 2026
2025-523781-25-00
Recruiting
PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS WITH MUSCLE INVASIVE BLADDER CANCER (MIBC) OR LOCALIZED OR LOCALLY ADVANCED RENAL CELL CANCER (RCC).
Phase 1 · Netherlands · 4 sites
Registry update: 14 Sept 2026
NCT07589413
Recruiting
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Not applicable · China · 1 site
Registry update: 15 May 2026
NCT07420517
Recruiting
Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Phase 2 · Canada · 1 site
Registry update: 30 Mar 2026
NCT07144319
Recruiting
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Not applicable · Belgium, Canada, Germany, Norway, United States · 12 sites
Registry update: 29 Oct 2026
NCT07080333
Recruiting
MICROBIOTA AND BLADDER CANCER
Not applicable · France · 8 sites
Registry update: 26 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.